Benitec Biopharma Inc./$BNTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Ticker
$BNTC
Sector
Primary listing
Employees
19
Headquarters
Website
BNTC Metrics
BasicAdvanced
$389m
-
-$0.93
0.28
-
Price and volume
Market cap
$389m
Beta
0.28
52-week high
$17.10
52-week low
$9.85
Average daily volume
88k
Financial strength
Current ratio
56.816
Quick ratio
56.434
Long term debt to equity
0.215
Total debt to equity
0.478
Profitability
EBITDA (TTM)
-46.541
Management effectiveness
Return on assets (TTM)
-19.93%
Return on equity (TTM)
-29.58%
Valuation
Price to book
2.12
Price to tangible book (TTM)
2.12
Price to free cash flow (TTM)
-25.434
Free cash flow yield (TTM)
-3.93%
Free cash flow per share (TTM)
-0.445
Growth
Earnings per share change (TTM)
-10.64%
3-year earnings per share growth (CAGR)
-62.87%
10-year earnings per share growth (CAGR)
-47.81%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs